Anavex Life Sciences Statistics
Total Valuation
AVXL has a market cap or net worth of $731.79 million. The enterprise value is $593.03 million.
Important Dates
The next estimated earnings date is Wednesday, February 5, 2025, before market open.
Earnings Date | Feb 5, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
AVXL has 84.80 million shares outstanding. The number of shares has increased by 5.06% in one year.
Current Share Class | 84.80M |
Shares Outstanding | 84.80M |
Shares Change (YoY) | +5.06% |
Shares Change (QoQ) | +2.51% |
Owned by Insiders (%) | 3.05% |
Owned by Institutions (%) | 32.18% |
Float | 82.21M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | 9.01 |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 5.64 |
P/TBV Ratio | 5.64 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 12.04
Current Ratio | 12.04 |
Quick Ratio | 11.95 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -30.03% and return on invested capital (ROIC) is -22.12%.
Return on Equity (ROE) | -30.03% |
Return on Assets (ROA) | -20.43% |
Return on Capital (ROIC) | -22.12% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.04M |
Employee Count | 40 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
In the past 12 months, AVXL has paid $60,000 in taxes.
Income Tax | 60,000 |
Effective Tax Rate | n/a |
Dividends & Yields
AVXL does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -5.06% |
Shareholder Yield | -5.06% |
Earnings Yield | -5.67% |
FCF Yield | -4.10% |
Analyst Forecast
The average price target for AVXL is $43.00, which is 398.26% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $43.00 |
Price Target Difference | 398.26% |
Analyst Consensus | Strong Buy |
Analyst Count | 2 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
The last stock split was on October 7, 2015. It was a reverse split with a ratio of 0.25:1.
Last Split Date | Oct 7, 2015 |
Split Type | Reverse |
Split Ratio | 0.25:1 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |